logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

MEGA GENOMICS (06667) repurchased 94,800 shares for HKD 682,500 on September 30.

date
21:10 30/09/2026
avatar
GMT Eight
MEGA GENOMICS (06667) announced that on September 30, 2026, the company repurchased 94,800 shares for HKD 682,500, at a repurchase price of HKD 7.185-7.29 per share.
MEGA GENOMICS (06667) announced that on September 30, 2026, the company repurchased 94,800 shares for HKD 682,500, at a repurchase price of HKD 7.185-7.29 per share.
Related Articles
HK Stock
CON AERO TECH (00232) will distribute a cash dividend of HK$0.0073 per share on October 8.
HK Stock
C CARBONNEUTRAL (01372) Announces Annual Results, Shareholders' Loss Attributable at HK$185 Million, Up 2388% Year-on-Year
US Stock Market Move | HUTCHMED (HCM.US) rises over 3% on submission of New Drug Application to FDA for the combination therapy of ORPATHYS plus TAGRISSO
CON AERO TECH (00232) will distribute a cash dividend of HK$0.0073 per share on October 8.
HK Stock
C CARBONNEUTRAL (01372) Announces Annual Results, Shareholders' Loss Attributable at HK$185 Million, Up 2388% Year-on-Year
HK Stock
US Stock Market Move | HUTCHMED (HCM.US) rises over 3% on submission of New Drug Application to FDA for the combination therapy of ORPATHYS plus TAGRISSO
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.